Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Toronto
$70,000.00
Large-Scale Genotyping Initiatives in the Developing World
FY 2008-09
Summary
In 2002, the World Health Organization recommended that countries in the developing world invest in genomics despite the challenges associated with cost, accessibility and delivery. In line with this recommendation, emerging economy governments in Mexico, India, Thailand and South Africa have chosen to fund large-scale human genotyping initiatives. Of particular interest is the reference made by these countries to genomic sovereignty, a concept which implies state ownership of genetic samples and the resulting data. The concept is linked to their desire to capture the value of their investments in these initiatives. However, human genomic data will likely require interpretation through large international collaborative efforts before it can generate practical health benefits and while participants lamented the 'poaching' of samples from their countries, they were also concerned that 'genomic sovereignty' legislation might inhibit these collaborations.
This research describes an analysis of these four initiatives with respect to their investments in genomics in the developing world towards global health equity and economic development. Specific objectives are to: a) provide a brief analysis of the motivations, challenges, opportunities and the potential implications to conducting large-scale genotyping projects documenting human genomic variation in the developing world, as identified in the above listed countries; b) provide an in-depth illustration of genomic sovereignty, through an exploration of the empirical and theoretical understandings of the concept, focusing on how it may contribute to each country's aim of achieving health equity through investments in genomics as well as its potential limitations. This analysis will serve to identify unique lessons learnt, good practices and potential models and will be of interest to those interested in the intersection of genomics with public health in the developing world.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
184364
Name
Hardy Billie Jo
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
Large-Scale Genotyping Initiatives in the Developing World
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Ethical; Genomic Sovereignty; Genomics And Global Health; Global Health; Health Equity; International Development; Legal; Population Health; Public Health Genomics; Qualitative Research; Science And Technology Policy; Social Issues
Abstract
In 2002, the World Health Organization recommended that countries in the developing world invest in genomics despite the challenges associated with cost, accessibility and delivery. In line with this recommendation, emerging economy governments in Mexico, India, Thailand and South Africa have chosen to fund large-scale human genotyping initiatives. Of particular interest is the reference made by these countries to genomic sovereignty, a concept which implies state ownership of genetic samples and the resulting data. The concept is linked to their desire to capture the value of their investments in these initiatives. However, human genomic data will likely require interpretation through large international collaborative efforts before it can generate practical health benefits and while participants lamented the 'poaching' of samples from their countries, they were also concerned that 'genomic sovereignty' legislation might inhibit these collaborations.
This research describes an analysis of these four initiatives with respect to their investments in genomics in the developing world towards global health equity and economic development. Specific objectives are to: a) provide a brief analysis of the motivations, challenges, opportunities and the potential implications to conducting large-scale genotyping projects documenting human genomic variation in the developing world, as identified in the above listed countries; b) provide an in-depth illustration of genomic sovereignty, through an exploration of the empirical and theoretical understandings of the concept, focusing on how it may contribute to each country's aim of achieving health equity through investments in genomics as well as its potential limitations. This analysis will serve to identify unique lessons learnt, good practices and potential models and will be of interest to those interested in the intersection of genomics with public health in the developing world.
Competitiondate
200810
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Hardy, Billie Jo
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $70,000~ $0~